Phospholipid drug conjugate (PDC) / phospholipid ether drug conjugate delivery platform that specifically targets cancer cells; enables radioconjugate programs (phospholipid radioconjugates, PRCs) designed to deliver radioisotopes directly to cancer cells while limiting exposure to healthy cells; focus area: oncology

Phospholipid Drug Conjugate

PDC (Phospholipid Drug Conjugate) delivery platform for cancer cell-targeting treatments; enables targeted delivery of radioisotopes and chemotherapeutics to cancer cells with improved efficacy and reduced off-target effects across multiple oncology indications

Discontinued (3)

iopofosine — Neuroblastoma
iopofosine — Osteosarcoma
iopofosine — Ewing's Sarcoma

Biotech Distilled coverage (1)

2026-05-07 Cellectar Biosciences (CLRB) - Scientific Deep Dive for Iopofosine and Pipeline Products

Articles open on Substack. Some deep dives are subscriber-only.